Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Plvap/PV1 Critical to Formation of… >

Plvap/PV1 Critical to Formation of the Diaphragms in Endothelial Cells

Published: January 3, 2013.
Released by Dartmouth-Hitchcock Medical Center  

Dartmouth scientists have demonstrated the importance of the gene Plvap and the structures it forms in mammalian physiology in a study published in December by the journal Developmental Cell.

"The knowledge generated and the animal models created will allow a better understanding of the role of the gene in diseases and will help validate its usefulness as a therapeutic or diagnostic target," said lead author Radu V. Stan, MD, associate professor, Geisel School of Medicine at Dartmouth, and member of the Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC).

The study demonstrates that plasmalemma vesicle associated protein (PV1), a vertebrate gene specifically expressed in the vascular endothelial cells, is critical for the formation of the diaphragms of endothelial caveolae, fenestrae and transendothelial channels. Although discovered in the 1960s by electron microscopy, the function of the diaphragms was previously unknown. Using mice with loss and gain of PV1 function Dartmouth scientists demonstrated that the diaphragms of fenestrae are critical for maintenance of basal permeability, the homeostasis of blood plasma in terms of protein and lipid blood composition, and ultimately survival.

PV1 has newly discovered roles in cancer and in various infectious and inflammatory diseases. "The knowledge generated and the animal models created will allow a better understanding of the role of the gene in these diseases and to validate its usefulness as a therapeutic or diagnostic target," said Stan.

In the absence of such diaphragms, plasma protein extravasation produces a noninflammatory protein-losing enteropathy resulting in protein calorie malnutrition and ultimately death.

"Our results and the mouse models we have created provide the foundations for evaluating numerous aspects of basal permeability in fenestrated vascular beds," said Stan.




The above story is based on materials provided by Dartmouth-Hitchcock Medical Center.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Protein 
6/5/14 
★★ 
Design of Self-assembling Protein Nanomachines Starts to Click
A route for constructing protein nanomachines engineered for specific applications may be closer to reality. Biological systems produce …
Modeling 
11/18/14 
New Computational Model Could Design Medications Like Chemotherapy with Fewer Side Effects
Medications, such as chemotherapy, are often limited by their tendency to be detrimental to healthy cells as an unintended …
Protein 
4/11/10 
NTU Researchers Make Significant Findings About Protein Architecture - Breakthrough May Aid in Drug Design, Generation of Unique Nanomaterials with Applications Beyond Medicine
Researchers from Nanyang Technological University’s (NTU) School of Physical and Mathematical Sciences (SPMS) have taken a major step forward …
Protein 
1/28/15 
Dartmouth Investigators Conduct Systematic Testing of Deimmunized Biotherapeutic Agents
(Lebanon, NH 1/28/15) By establishing protein design algorithms that simultaneously optimize drug candidates for both decreased immunogenic epitope content …
Model 
11/11/10 
Scientists at IRB Barcelona And BSC Publish the World’s Largest Video Data Bank of Proteins for the Pharmaceutical Industry
The new data base, which includes 1,700 proteins in motion, allows a more efficient design of drugs. MoDEL holds …
Calcium 
6/6/14 
Scientists Reveal Details of Calcium 'Safety-valve' in Cells
UPTON, NY -- Sometimes a cell has to die-when it's done with its job or inflicted with injury that …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile